Metabolic Testing Market: Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Metabolic Testing Market: By Equipment Type (Body Composition Analyzers, Cardiopulmonary Exercise Testing (CPET) Systems, ECG Systems, Metabolic Carts, Others), By Application (Critical Care, Lifestyle Diseases), By End User (Hospitals and Clinics, Sports Training Centers, Others) and Geography

 

 

 

 

 

 

 

 

 

 

 

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Metabolic Testing Market size is estimated to be valued at USD 541.3 Million in 2021 and is poised to grow at a significant CAGR of 7.6% over 2022-2028. Metabolic tests determine how quickly the patient’s body burns calories, and these also measure the amount of oxygen used during rest and physical activity. Several years ago, metabolic testing could only be performed in an expensive hospital or laboratory setting. Nowadays, gyms and health clubs are giving metabolic assessments utilizing low-cost equipment. The processes and equipment used in a gym or health spa setting are frequently like the protocols and equipment used in a hospital setting. Based on the application type, the market is segmented into Critical Care, Lifestyle Diseases. The lifestyle Diseases segment is anticipated to grow at a significant CAGR over the forecast years owing to increased lifestyle disorders such as atherosclerosis, heart disease, obesity, and type 2 diabetes, as well as smoking cessation aids and alcohol use. Lifestyle and nutritional habits have distinct implications on cardiometabolic disease and other metabolic disorders. According to the World Health Organization (WHO), at least 2.8 million people die each year due to obesity, and nearly 17 million people die each year from cardiovascular diseases. The increased prevalence of lifestyle disorders such as cardiovascular disease, diabetes, and obesity are the primary drivers for the analysed industry. The rising frequency of lifestyle-related diseases and an aging population predisposed to chronic diseases such as cancer and renal problems are some of the primary reasons driving the metabolic testing market. Furthermore, technical improvements such as introducing digital metabolic rate testing equipment and fast-rising healthcare spending levels will likely drive market expansion throughout the projection period.

Key Developments:

In March 2022, to quantify the direct impact of dietary choices on metabolism, Lumen created a platform that enables users to log and track the nutritional value and macronutrients of each item (volumes of fats, carbs, and protein) each meal

Metabolic Testing Market

MARKET SUMMARY
-
7.6%
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 7.6%
  • Largest Market– North American
  • Fastest Growing Market– Asia-Pacific

Metabolic Testing Market

  • The metabolic testing market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • The metabolic testing market is segmented based on equipment type, application, end user and geography.
Key Players
  • MGC Diagnostics Corporation
  • COSMED srl
  • CORTEX Biophysik GmbH
  • GE Healthcare (General Electric Company)
  • KORR Medical Technologies, Inc
Metabolic Testing Market Dynamics

Being overweight is mainly caused by an increase in rapid social life and an unhealthy lifestyle, which drives the expansion of the metabolic testing market. Consumption of snacks, fat-containing meals, and rising disposable income contribute to market expansion. According to WHO, this contributes to lifestyle diseases such as cancer and chronic diseases. Cancer is the world’s second most significant cause of mortality, accounting for an estimated 9.6 million deaths in 2018. Cancer is responsible for around one in every six deaths worldwide. Cancer kills over 70% of people in low- and middle-income nations. However, a lack of awareness in other middle-income and low-income countries may hamper market expansion. Despite this, technological innovation, rising hospital service standards, and an expanding population are some of the reasons that may create more potential for market growth in the future.


North America Got Significant Share

Metabolic Testing Market

The Metabolic Testing market in North America is likely to hold the highest revenue share in 2021. The same trend is expected over the forecast period due to improvements in metabolic testing technology and the rising incidence of lifestyle-related disorders such as obesity and diabetes, rising healthcare expenditures, a large patient pool, an increase in the level of life, and increased government support in the region, Asia-Pacific is the fastest expanding region in the worldwide metabolic testing market. Furthermore, the metabolic testing market is expanding & with rising healthcare awareness and improved healthcare infrastructure in emerging markets such as India and China.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share and forecast from 2021-2027
  • The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
Metabolic Testing Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The global metabolic testing market is estimated to surpass US$ 541.3 Million in 2021.

Major players in the market include MGC Diagnostics Corporation, COSMED Srl, CORTEX Biophysik GmbH, GE Healthcare (General Electric Company), KORR Medical Technologies, Inc, CareFusion Corporation, Geratherm Medical AG, OSI Systems, Inc, AEI Technologies Inc, Parvo Medics.

Among the equipment type, the Body Composition Analyzers accounts for the highest demand in the global metabolic testing devices in 2020.

North America held the highest share in 2021.


Report

Table Of Content

1. Executive Summary
2. Global Metabolic Testing Market Introduction
2.1. Global Metabolic Testing Market – Taxonomy
2.2. Global Metabolic Testing Market –Definitions
2.2.1.  By Equipment Type
2.2.2. By Application
2.2.3. By End User
2.2.4. By Region
3. Global Metabolic Testing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Metabolic Testing Market Dynamic Factors – Impact Analysis
3.6. Global Metabolic Testing Market – Competition Landscape
4. Global Metabolic Testing Market Analysis,2017-2021 and Forecast, 2022-2028
4.1. Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Metabolic Testing Market, By Equipment Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Body Composition Analyzers
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Cardiopulmonary Exercise Testing (CPET) Systems
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. ECG Systems
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Metabolic Carts
5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. others
5.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. Global Metabolic Testing Market Forecast, By Application, 2017-2021 and Forecast, 2021 – 2027 (Revenue, USD Mn)
6.1. Critical Care
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Lifestyle Diseases
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Metabolic Testing Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Hospitals and Clinics
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Sports Training Centers
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Metabolic Testing Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Metabolic Testing Market – Opportunity Analysis Index, By Equipment Type, By Application, End User, and Region, 2022-2028
9. North America Metabolic Testing Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. By Equipment Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Body Composition Analyzers
9.1.2. Cardiopulmonary Exercise Testing (CPET) Systems
9.1.3. ECG Systems
9.1.4. Metabolic Carts
9.1.5. Others
9.2. By Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Critical Care
9.2.2. Lifestyle Diseases
9.3. By End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Hospitals and Clinics
9.3.2. Sports Training Centers
9.3.3. Others
9.4. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. USA
9.4.2. Canada
9.5. North America Metabolic Testing Market – Opportunity Analysis Index, By Equipment Type, By Application, End User, and Country, 2022-2028
9.6. North America Metabolic Testing Market Dynamics – Trends
10. Europe Metabolic Testing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. By Equipment Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Body Composition Analyzers
10.1.2. Cardiopulmonary Exercise Testing (CPET) Systems
10.1.3. ECG Systems
10.1.4. Metabolic Carts
10.1.5. Others
10.2. By Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Critical Care
10.2.2. Lifestyle Diseases
10.3. By End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Hospitals and Clinics
10.3.2. Sports Training Centers
10.3.3. Others
10.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Metabolic Testing Market – Opportunity Analysis Index, By Equipment Type, By Application, End User, and Country, 2022-2028
10.6. Europe Metabolic Testing Market Dynamics – Trends
11. Asia-Pacific Metabolic Testing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. By Equipment Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Body Composition Analyzers
11.1.2. Cardiopulmonary Exercise Testing (CPET) Systems
11.1.3. ECG Systems
11.1.4. Metabolic Carts
11.1.5. Others
11.2. By Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Critical Care
11.2.2. Lifestyle Diseases
11.3. By End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Hospitals and Clinics
11.3.2. Sports Training Centers
11.3.3. Others
11.4. Country Analysis2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Metabolic Testing Market – Opportunity Analysis Index, By Equipment Type, By Application, End User, and Country, 2022-2028
11.6. Asia-Pacific Metabolic Testing Market Dynamics – Trends
12. Latin America Metabolic Testing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. By Equipment Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Body Composition Analyzers
12.1.2. Cardiopulmonary Exercise Testing (CPET) Systems
12.1.3. ECG Systems
12.1.4. Metabolic Carts
12.1.5. Others
12.2. By Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Critical Care
12.2.2. Lifestyle Diseases
12.3. By End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Hospitals and Clinics
12.3.2. Sports Training Centers
12.3.3. Others
12.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Rest of Latin America
12.5. Latin America Metabolic Testing Market – Opportunity Analysis Index, By Equipment Type, By Application, End User, and Country, 2022-2028
12.6. Latin America Metabolic Testing Market Dynamics – Trends
13. Middle East and Africa Metabolic Testing Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. By Equipment Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Body Composition Analyzers
13.1.2. Cardiopulmonary Exercise Testing (CPET) Systems
13.1.3. ECG Systems
13.1.4. Metabolic Carts
13.1.5. Others
13.2. By Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Critical Care
13.2.2. Lifestyle Diseases
13.3. By End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Hospitals and Clinics
13.3.2. Sports Training Centers
13.3.3. Others
13.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Metabolic Testing Market – Opportunity Analysis Index, By Equipment Type, By Application, End User, and Country, 2022-2028
13.6. MEA Metabolic Testing Market Dynamics – Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, By Application & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. MGC Diagnostics Corporation
14.2.2. COSMED srl
14.2.3. CORTEX Biophysik GmbH
14.2.4. GE Healthcare (General Electric Company)
14.2.5. KORR Medical Technologies, Inc
14.2.6. CareFusion Corporation
14.2.7. Geratherm Medical AG
14.2.8. OSI Systems, Inc
14.2.9. AEI Technologies, Inc
14.2.10. Parvo Medics
15. Research Methodology
16. Key Assumptions and Acronyms

Report

Company Profile

  • MGC Diagnostics Corporation
  • COSMED srl
  • CORTEX Biophysik GmbH
  • GE Healthcare (General Electric Company)
  • KORR Medical Technologies, Inc
  • CareFusion Corporation
  • Geratherm Medical AG
  • OSI Systems, Inc
  • AEI Technologies, Inc
  • Parvo Medicsystems, Inc

Description

Metabolic Testing Market size is estimated to be valued at USD 541.3 Million in 2021 and is poised to grow at a significant CAGR of 7.6% over 2022-2028. Metabolic tests determine how quickly the patient’s body burns calories, and these also measure the amount of oxygen used during rest and physical activity. Several years ago, metabolic testing could only be performed in an expensive hospital or laboratory setting. Nowadays, gyms and health clubs are giving metabolic assessments utilizing low-cost equipment. The processes and equipment used in a gym or health spa setting are frequently like the protocols and equipment used in a hospital setting. Based on the application type, the market is segmented into Critical Care, Lifestyle Diseases. The lifestyle Diseases segment is anticipated to grow at a significant CAGR over the forecast years owing to increased lifestyle disorders such as atherosclerosis, heart disease, obesity, and type 2 diabetes, as well as smoking cessation aids and alcohol use. Lifestyle and nutritional habits have distinct implications on cardiometabolic disease and other metabolic disorders. According to the World Health Organization (WHO), at least 2.8 million people die each year due to obesity, and nearly 17 million people die each year from cardiovascular diseases. The increased prevalence of lifestyle disorders such as cardiovascular disease, diabetes, and obesity are the primary drivers for the analysed industry. The rising frequency of lifestyle-related diseases and an aging population predisposed to chronic diseases such as cancer and renal problems are some of the primary reasons driving the metabolic testing market. Furthermore, technical improvements such as introducing digital metabolic rate testing equipment and fast-rising healthcare spending levels will likely drive market expansion throughout the projection period.

Key Developments:

In March 2022, to quantify the direct impact of dietary choices on metabolism, Lumen created a platform that enables users to log and track the nutritional value and macronutrients of each item (volumes of fats, carbs, and protein) each meal

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX